Dr. Reddy’s Laboratories has launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE (Sirolimus) tablets in the US market on October 27, 2014, following the approval by the United States Food & Drug Administration (USFDA). The company’s Sirolimus tablets in 1 mg and 2 mg are available in bottle counts of 100.
Real Time News & Trading Trends Keep Liking#EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin –Google+
For more information ✆ – 0731-6642300 or Visithttp://ift.tt/1k8NnLH
0 comments:
Post a Comment